reithera srl

Exhibitor

ReiThera Srl is a CDMO specialized in the development of scalable processes and GMP manufacturing of viral vectors for gene therapies, genetic vaccines, and advanced medicinal products. With extensive expertise in viral vector production—including Adeno-Associated Virus (AAV), Lentivirus, Adenoviral Vector (AdV), Vaccinia lineage vectors, and Herpes Simplex Vector—ReiThera supports the clinical translation of innovative therapies. The company state-of-the-art facility in Rome, Italy is equipped with stirred-tank bioreactors ranging from 2L to 2000L, fixed-bed bioreactors for adherent cell growth, filling suites, and advanced quality control laboratories. ReiThera’s manufacturing capabilities cover both small- and large-scale production, ensuring rapid transitions from laboratory to clinical and commercial GMP-grade material by using validated platform including:

- Vaccinia lineage platform: MVA vector strains, production Cell Lines, Validated manufacturing process at different scale in a GMP class B area, fill & finish, Validated analytical SOP

- Adenoviral GRAd platform: GRAd platform for vector generation, Production Cell Lines, fast process verification and transfer to GMP, validated GMP processes at different scales, fill & finish, Validated analytical methods

- ReicellAVV Cell Line for AAV vector production for Gene Therapy.

ReiThera has demonstrated its ability to respond quickly to global health challenges through collaborations with research institutes, pharmaceutical companies, and international partners, solidifying its position as a leading Italian company in the biotechnology sector.